News Home

Protalix Biotherapeutics Inc (PLX) Up 1.76% in Premarket Trading

Thursday, September 09, 2021 08:33 AM | InvestorsObserver Analysts
Protalix Biotherapeutics Inc (PLX) Up 1.76% in Premarket Trading

Protalix Biotherapeutics Inc (PLX) has gained Thursday morning, with the stock gaining 1.76% in pre-market trading to 1.73. PLX's short-term technical score of 20 indicates that the stock has traded less bullishly over the last month than 80% of stocks on the market. In the Biotechnology industry, which ranks 137 out of 146 industries, the stock ranks higher than 41% of stocks. Protalix Biotherapeutics Inc has risen 5.59% over the past month, closing at $1.48 on August 12. During this period of time, the stock fell as low as $1.31 and as high as $1.78. PLX has an average analyst recommendation of Strong Buy. The company has an average price target of $9.75.

Overall Score - 37
PLX has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on PLX!
Protalix Biotherapeutics Inc has a Long-Term Technical rank of 6. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 94% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, PLX ranks better than 15% of stocks.

Important Dates for Investors in PLX:

-Protalix Biotherapeutics Inc is set to release earnings on 11/4/2021. During their last earnings release the company posted EPS of $-0.50. -We do not have a set dividend date for Protalix Biotherapeutics Inc at this time. Click Here To Get The Full Report on Protalix Biotherapeutics Inc (PLX)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App